Aurinia Pharmaceuticals Inc. (AUPH)

USD 9.1

(-4.71%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 548.06 Million 470.86 Million 543.36 Million 463.66 Million 326.68 Million 145.86 Million
Total Current Assets 424.8 Million 442.53 Million 513.32 Million 419.42 Million 315.13 Million 132.84 Million
Cash And Short Term Investments 350.48 Million 389.39 Million 466.07 Million 398.32 Million 306.01 Million 125.85 Million
Cash and Cash Equivalents 48.87 Million 94.17 Million 231.9 Million 272.35 Million 306.01 Million 117.96 Million
Short Term Investments 301.61 Million 295.21 Million 234.17 Million 125.97 Million - 7.88 Million
Net Receivables 24.08 Million 13.48 Million 15.41 Million 1.01 Million 368 Thousand 217 Thousand
Inventory 39.7 Million 24.75 Million 19.32 Million 13.92 Million - -
Other Current Assets 10.51 Million 1.33 Million 796 Thousand 6.15 Million 8.75 Million 6.77 Million
Total Non-Current Assets 123.26 Million 28.32 Million 30.04 Million 44.23 Million 11.54 Million 13.01 Million
Net PPE 116.56 Million 8.55 Million 9.8 Million 10.27 Million 93 Thousand 41 Thousand
Good Will And Intangible Assets 4.97 Million 6.42 Million 8.4 Million 9.33 Million 11.24 Million 12.61 Million
Good Will - - - - - -
Intangible Assets 4.97 Million 6.42 Million 8.4 Million 9.33 Million 11.24 Million 12.61 Million
Long-Term Investments 201 Thousand - - 24.38 Million - -
Tax Assets - - - - - -
Other Non Current Assets 1.51 Million 13.33 Million 11.83 Million 247 Thousand 209 Thousand 358 Thousand
Other Assets - - - - - -
Total Liabilities 170.1 Million 65.42 Million 64.27 Million 55.91 Million 53.16 Million 33.28 Million
Total Current Liabilities 77.18 Million 46.1 Million 40.64 Million 31.99 Million 11.29 Million 7.26 Million
Account Payables 4.32 Million 3.08 Million 3.87 Million 2.63 Million 4.15 Million 7.07 Million
Tax Payables 667 Thousand 625 Thousand 814 Thousand - - -
Short Term Debt 15.59 Million 936 Thousand 1.05 Million 788 Thousand 6.9 Million -118 Thousand
Deferred Revenue 4.81 Million 3.14 Million 31.06 Million 21.37 Million 118 Thousand 118 Thousand
Other Current Liabilities 52.45 Million 38.93 Million 4.64 Million 7.2 Million 118 Thousand 190 Thousand
Total Non Current Liabilities 92.92 Million 19.31 Million 23.63 Million 23.91 Million 41.87 Million 26.02 Million
Long-Term Debt 82 Million 7.15 Million 7.68 Million 7.61 Million - -
Deferred Revenue Non Current - - - 207 Thousand 206 Thousand 324 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 10.91 Million 12.16 Million 15.95 Million 16.29 Million 41.66 Million 25.7 Million
Other Liabilities - - - - - -
Total Equity 377.95 Million 405.43 Million 479.09 Million 407.75 Million 273.51 Million 112.57 Million
Stock Holders Equity 377.95 Million 405.43 Million 479.09 Million 407.75 Million 273.51 Million 112.57 Million
Common Stock 1.2 Billion 1.18 Billion 1.17 Billion 944.32 Million 790.47 Million 504.65 Million
Retained Earnings -942.32 Million -864.3 Million -756.12 Million -575.15 Million -539.8 Million -415.96 Million
Accumulated other comprehensive income -730 Thousand -1.06 Million -852 Thousand -805 Thousand -805 Thousand -805 Thousand
Common Stock Equity 377.95 Million 405.43 Million 479.09 Million 407.75 Million 273.51 Million 112.57 Million
Capital Lease Obligation 82 Million 8.08 Million 8.73 Million 8.4 Million - -
Total Investments 301.81 Million 295.21 Million 234.17 Million 150.35 Million - 7.88 Million
Total Debt 97.6 Million 8.08 Million 8.73 Million 8.4 Million - -
Net Debt 48.73 Million -86.08 Million -223.16 Million -263.94 Million -306.01 Million -117.96 Million

Balance Sheet Charts